Anterix (ATEX) Director Mahvash Receives 1,598-Share Award

What Happened Mahvash Yazdi, a director of Anterix Inc. (ATEX), received a grant of 1,598 restricted common shares on August 4, 2026. The grant is reported on the Form 4 as an award (code A) with a reported acquisition price of $0 and a reported total value of $0. This is a compensation grant to the director, not an open-market purchase or sale.

Key Details

• Transaction date and type: 2026-08-04 — Award/Grant of 1,598 shares (code A) at $0.00 per share.
• Filing date: Form 4 filed 2026-08-06 (filed within two business days of the transaction).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Vesting: Footnote F1 — shares vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the Restricted Stock Agreement.
• Ownership/beneficial interest: Footnote F2 — Ms. Yazdi is trustee of the Yazdi Family Trust UA Oct 03, 1998 and has voting and dispositive power over these shares; she disclaims beneficial ownership except for her pecuniary interest.

Context Restricted stock awards to directors are a common form of compensation and are subject to vesting, meaning the recipient cannot freely transfer the shares until vesting conditions are met. Because this was a grant (not a purchase or sale), it should be viewed as remuneration rather than a direct signal of the director buying or selling company stock.